These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 22740622)

  • 21. von Willebrand disease: a clinical and laboratory study of sixty-five patients.
    Chen YC; Yang L; Cheng SN; Hu SH; Chao TY
    Ann Hematol; 2011 Oct; 90(10):1183-90. PubMed ID: 21643680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation of a rapid test (VWF-LIA) for the quantitative determination of von Willebrand factor antigen in type 1 von Willebrand disease diagnosis within the European multicenter study MCMDM-1VWD.
    Castaman G; Tosetto A; Cappelletti A; Goodeve A; Federici AB; Batlle J; Meyer D; Goudemand J; Eikenboom JC; Schneppenheim R; Budde U; Ingerslev J; Lethagen S; Hill F; Peake IR; Rodeghiero F
    Thromb Res; 2010 Sep; 126(3):227-31. PubMed ID: 20650506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of ABO(H) and I blood group system development with von Willebrand factor and Factor VIII plasma levels in children and adolescents.
    Klarmann D; Eggert C; Geisen C; Becker S; Seifried E; Klingebiel T; Kreuz W
    Transfusion; 2010 Jul; 50(7):1571-80. PubMed ID: 20210927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison between von Willebrand factor (VWF) and VWF antigen II in normal individuals and patients with von Willebrand disease.
    de Romeuf C; Mazurier C
    Thromb Haemost; 1998 Jul; 80(1):37-41. PubMed ID: 9684782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma concentrations of von Willebrand factor and intracellular adhesion molecule-1 for prediction of outcome after successful cardiopulmonary resuscitation.
    Geppert A; Zorn G; Delle-Karth G; Koreny M; Siostrzonek P; Heinz G; Huber K
    Crit Care Med; 2003 Mar; 31(3):805-11. PubMed ID: 12626988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device.
    Meyer AL; Malehsa D; Bara C; Budde U; Slaughter MS; Haverich A; Strueber M
    Circ Heart Fail; 2010 Nov; 3(6):675-81. PubMed ID: 20739614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet von Willebrand factor determination does not improve the diagnosis of patients with suspected Type 1 von Willebrand disease.
    Shihong I; Morris D; Konkle BA
    Haemophilia; 2009 Jan; 15(1):131-4. PubMed ID: 18976254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biological and clinical response to desmopressin (DDAVP) in a retrospective cohort study of children with low von Willebrand factor levels and bleeding history.
    Sánchez-Luceros A; Meschengieser SS; Woods AI; Chuit R; Turdó K; Blanco A; Lazzari MA
    Thromb Haemost; 2010 Nov; 104(5):984-9. PubMed ID: 20886181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monitoring disease activity in juvenile dermatomyositis: the role of von Willebrand factor and muscle enzymes.
    Guzmán J; Petty RE; Malleson PN
    J Rheumatol; 1994 Apr; 21(4):739-43. PubMed ID: 8035403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosing central nervous system vasculitis in children.
    Cellucci T; Benseler SM
    Curr Opin Pediatr; 2010 Dec; 22(6):731-8. PubMed ID: 21610331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of von Willebrand factor activity in factor VIII/von Willebrand factor concentrates with the automated von Willebrand factor: activity IL test.
    Mori F; Rossi P; Nardini I; Gambelli D; Farina C
    Blood Coagul Fibrinolysis; 2010 Apr; 21(3):221-8. PubMed ID: 20179578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bleeding tendency and efficacy of anti-haemorrhagic treatments in patients with type 1 von Willebrand disease and increased von Willebrand factor clearance.
    Castaman G; Tosetto A; Federici AB; Rodeghiero F
    Thromb Haemost; 2011 Apr; 105(4):647-54. PubMed ID: 21264446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The anti-von Willebrand factor aptamer ARC1779 increases von Willebrand factor levels and platelet counts in patients with type 2B von Willebrand disease.
    Jilma-Stohlawetz P; Knöbl P; Gilbert JC; Jilma B
    Thromb Haemost; 2012 Aug; 108(2):284-90. PubMed ID: 22740102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.
    Michiels JJ; van de Velde A; van Vliet HH; van der Planken M; Schroyens W; Berneman Z
    Semin Thromb Hemost; 2002 Apr; 28(2):111-32. PubMed ID: 11992235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening for von Willebrand disease: contribution of an automated assay for von Willebrand factor activity.
    Lasne D; Dey C; Dautzenberg MD; Cherqaoui Z; Monge F; Aouba A; Torchet MF; Geloen D; Landais P; Rothschild C
    Haemophilia; 2012 May; 18(3):e158-63. PubMed ID: 21951857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Soluble intercellular adhesion molecule-1 and E-selectin as markers of disease activity and endothelial activation in juvenile idiopathic arthritis.
    Bloom BJ; Nelson SM; Eisenberg D; Alario AJ
    J Rheumatol; 2005 Feb; 32(2):366-72. PubMed ID: 15693101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
    Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
    Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New treatments of von Willebrand disease: plasma derived von Willebrand factor concentrates.
    Menache D; Aronson DL
    Thromb Haemost; 1997 Jul; 78(1):566-70. PubMed ID: 9198217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intracerebral hemorrhage with a favorable outcome in a patient with childhood primary angiitis of the central nervous system.
    Silva MF; Feitosa AR; Paz JA; Aikawa NE; Silva CA
    Rev Bras Reumatol Engl Ed; 2016; 56(4):366-70. PubMed ID: 27476630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An evaluation of the DDAVP infusion test with PFA-100 and vWF activity assays to distinguish vWD types in children.
    Akin M; Karapinar DY; Balkan C; Ay Y; Kavakli K
    Clin Appl Thromb Hemost; 2011 Oct; 17(5):441-8. PubMed ID: 20460340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.